Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-23-072487
Filing Date
2023-06-20
Accepted
2023-06-20 06:09:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2319110d2_defa14a.htm DEFA14A 27814
  Complete submission text file 0001104659-23-072487.txt   28963
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36598 | Film No.: 231023254
SIC: 2834 Pharmaceutical Preparations